[ASAP] Pharmacokinetic Considerations for Optimizing Inhaled Spray-Dried Pyrazinoic Acid Formulations 🔗 Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00199 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
